Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275307
Max Phase: Preclinical
Molecular Formula: C27H24N2O5S
Molecular Weight: 488.57
Associated Items:
ID: ALA5275307
Max Phase: Preclinical
Molecular Formula: C27H24N2O5S
Molecular Weight: 488.57
Associated Items:
Canonical SMILES: COc1cc(/C=C/c2ccc(OC(=O)CSc3nnc(-c4ccc(C)cc4)o3)cc2)cc(OC)c1
Standard InChI: InChI=1S/C27H24N2O5S/c1-18-4-10-21(11-5-18)26-28-29-27(34-26)35-17-25(30)33-22-12-8-19(9-13-22)6-7-20-14-23(31-2)16-24(15-20)32-3/h4-16H,17H2,1-3H3/b7-6+
Standard InChI Key: LQSOFPGQPTXZIF-VOTSOKGWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 488.57 | Molecular Weight (Monoisotopic): 488.1406 | AlogP: 5.93 | #Rotatable Bonds: 9 |
Polar Surface Area: 83.68 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.80 | CX LogD: 5.80 |
Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.12 | Np Likeness Score: -1.02 |
1. Ahmadi R, Ebrahimzadeh MA.. (2020) Resveratrol - A comprehensive review of recent advances in anticancer drug design and development., 200 [PMID:32485531] [10.1016/j.ejmech.2020.112356] |
Source(1):